NM_000428.3(LTBP2):c.1295C>T (p.Pro432Leu) AND Glaucoma 3, primary congenital, D

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Apr 28, 2017
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001117709.4

Allele description [Variation Report for NM_000428.3(LTBP2):c.1295C>T (p.Pro432Leu)]

NM_000428.3(LTBP2):c.1295C>T (p.Pro432Leu)

Gene:

LTBP2:latent transforming growth factor beta binding protein 2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

14q24.3

Genomic location:

Preferred name:

NM_000428.3(LTBP2):c.1295C>T (p.Pro432Leu)

HGVS:

NC_000014.9:g.74552291G>A
NG_021486.1:g.65041C>T
NM_000428.3:c.1295C>TMANE SELECT
NP_000419.1:p.Pro432Leu
NC_000014.8:g.75018994G>A
NM_000428.2:c.1295C>T

Protein change:

P432L

Links:

dbSNP: rs137854861

Molecular consequence:

NM_000428.3:c.1295C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Glaucoma 3, primary congenital, D
Identifiers:: MONDO: MONDO:0013122; MedGen: C2751316; Orphanet: 98976; OMIM: 613086

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001275927	Illumina Laboratory Services, Illumina	criteria provided, single submitter (ICSL Variant Classification Criteria 13 December 2019)	Uncertain significance (Apr 28, 2017)	germline	clinical testing	PubMed (1) [See all records that cite this PMID] Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001275927

Illumina Laboratory Services, Illumina

criteria provided, single submitter

(ICSL Variant Classification Criteria 13 December 2019)

Uncertain significance
(Apr 28, 2017)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Contribution of the latent transforming growth factor-β binding protein 2 gene to etiology of primary open angle glaucoma and pseudoexfoliation syndrome.

Jelodari-Mamaghani S, Haji-Seyed-Javadi R, Suri F, Nilforushan N, Yazdani S, Kamyab K, Elahi E.

Mol Vis. 2013;19:333-47. Epub 2013 Feb 7.

PubMed [citation]

PMID:: 23401661
PMCID:: PMC3568400

Details of each submission

From Illumina Laboratory Services, Illumina, SCV001275927.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Jun 20, 2026

ClinVar

Relating variation to medicine